R&D More than manufacturing: The value of a patient-centric CDMO For a biopharmaceutical company, contracting a CDMO that considers itself accountable to the patients can deliver a tangibly different experience.
Digital Sponsored The imperative for patient centricity in clinical research i... Read uMotif's Observations & Predictions on the imperative for patient centricity and stronger patient-site relationships in clinical research.
Patients Putting patients first: 5 strategic shifts making clinical t... From gamified digital platforms to remote sample collection and agile site activation, sponsors are reimagining trial design.
Patients Simplifying care to close the gap: Rethinking treatment burd... Simplifying the complexity of medical treatments extends beyond convenience to improving equity.
Oncology 5 clinical advances and related implications from ESMO 2025 5 particularly insightful takeaways from this year’s ESMO Congress that merit deeper reflection on where cancer care can go.
Patients The AI revolution will be patient-led The real AI revolution in healthcare won’t come from pharma’s AI investments, but from patients who refuse to wait.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.